Dr. Stephan Ebner-Benke is currently the head of study coordination and study director at QPS Austria GmbH and since 2018 he is also a senior project researcher and consultant at Winnovation Consulting in Vienna. Before this got his Master’s Degree Molecular Microbiology at the University of Graz. He then moved to Vienna to do his PhD in Molecular Biology at the University of Vienna. He graduated with honors in 2018 and in 2020 he got his executive MBA from the California Lutheran University.
Ceren Karacay started her scientific career with a Master’s degree in Regenerative Biology and Medicine at the Technical University of Dresden in 2014. She enrolled in the Ph.D. program at the Medical University of Graz in 2015. She will be finishing her Ph.D. in May 2023. In February 2021, she started working as a Regulatory Affairs Manager at Gerot Lannach, Styria, Austria.
	With 12 years of experience in immunobiology and cancer immunotherapy research, Dr. Pablo Vieyra-Garcia currently leads a biomarker integration group focused on oncology immunotherapy assets at Boehringer Ingelheim RCV. He obtained his Bachelor’s degree in biology and immunology at the National Autonomous University of Mexico following his Master's degree in immunology at The National Polytechnic Institute of Mexico. He relocated to Europe to obtain his doctoral degree at the Medical University of Graz working at the Department of Dermatology and Venereology. He continued his postdoctoral studies at the MUG. Dr. Vieyra-Garcia did his research stays as a Translational Medicine Research Trainee in the laboratory of Rachael Clark (Harvard Medical School, USA) and as visiting scientist at the Technical University of Munich under the EADV and the FRT fellowships. Since November 2021, he’s occupied the position of Principal Scientist at Boehringer Ingelheim RCV.